FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:1169-1170 September 14, 2006 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Spaulding, C. Related Article by Laarman, G. J. PubMed Citation

Primary percutaneous coronary intervention (PCI), when performed by an experienced team in a timely fashion, is a better reperfusion therapy than in-hospital thrombolysis in patients who have acute myocardial infarction with ST-segment elevation.^1,2 Although randomized trials of primary balloon angioplasty and primary stenting have not demonstrated a mortality benefit of primary stenting and have shown conflicting results with regard to the risk of reinfarction,^3,4 primary stenting of the infarct-related lesion has become standard treatment in most patients undergoing primary PCI.

Drug-eluting stents significantly reduce the risks of both restenosis and target-vessel revascularization after elective PCI, as compared with uncoated stents.^5,6 . . . [Full Text of this Article]

Source Information

From the University of Leuven, Leuven, Belgium.

Related Letters:

Drug-Eluting Stents in Primary PCI
Alfonso F., Jneid H., Maree A. O., Palacios I. F., Valgimigli M., Percoco G., Bolognese L., Spaulding C., Henry P., Teiger E., Laarman G. J., Van de Werf F.
Extract | Full Text | PDF  
N Engl J Med 2006; 355:2483-2486, Dec 7, 2006. Correspondence

This article has been cited by other articles:

• Kushner, F. G., Hand, M., Smith, S. C. Jr, King, S. B. III, Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E. R., Blankenship, J. C., Casey, D. E. Jr, Green, L. A., Hochman, J. S., Jacobs, A. K., Krumholz, H. M., Morrison, D. A., Ornato, J. P., Pearle, D. L., Peterson, E. D., Sloan, M. A., Whitlow, P. L., Williams, D. O. (2009). 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 54: 2205-2241 [Full Text]  
• Bates, E. R. (2008). Primary Percutaneous Coronary Intervention With Drug-Eluting Stents: Another Chapter in the Stent Controversy. Circ Cardiovasc Interv 1: 87-89 [Full Text]  
• Padera, R. F. Jr., Schoen, F. J. (2008). Pathology of Cardiac Surgery. Card Surg Adult 3: 111-178 [Full Text]  
• (2006). Drug Eluting Stents for Primary PCI in STEMI. Journal Watch Cardiology 2006: 5-5 [Full Text]  
• Alfonso, F., Jneid, H., Maree, A. O., Palacios, I. F., Valgimigli, M., Percoco, G., Bolognese, L., Spaulding, C., Henry, P., Teiger, E., Laarman, G. J., Van de Werf, F. (2006). Drug-eluting stents in primary PCI.. NEJM 355: 2483-2484 [Full Text]  
• (2006). Drug-Eluting Stents for ST-Segment Elevation MI?. JWatch General 2006: 1-1 [Full Text]  
• (2006). Drug Eluting Stents for Primary PCI in STEMI. Journal Watch Cardiology 2006: 1-1 [Full Text]